Please login to the form below

Aspen

This page shows the latest Aspen news and features for those working in and with pharma, biotech and healthcare.

Grünenthal buys Zomig rights as AZ slimming drive continues

This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood

Latest news

EU starts investigation of Aspen's cancer drug pricing

EU starts investigation of Aspen's cancer drug pricing. Amid reports of price increases of several hundred per cent. ... Aspen Pharmacare is under investigation by the EU's competition authorities over its pricing of five cancer medicines, amid
Italian pharma scandals prompts call for EU-wide pricing probe

Italian pharma scandals prompts call for EU-wide pricing probe. Aspen fined 5.2m for threat to halt supply of cancer drugs if price hikes not accepted. ... The negotiation strategy adopted by Aspen was so aggressive as to reach the credible threat of
AstraZeneca sells rights to seven anaesthetics in $770m deal

AstraZeneca sells rights to seven anaesthetics in $770m deal. Ten-year agreement with Aspen continues the streamlining of its operations. ... AstraZeneca has divested seven drugs from its anaesthetics portfolio through a $770m deal with Aspen Global
Endo buys Par for $8bn as M&A mania marches on

All told Endo has already spent around $10bn on M&A in recent months, closing a generics deal with South Africa's Aspen Holdings earlier this month.
GSK sells another chunk of South Africa's Aspen

GSK sells another chunk of South Africa's Aspen. Paid $418m for an 18% share in Aspen in 2009. ... We continue to believe in the strategy of Aspen and we remain committed to working together in the future," said Dingemans.

More from news
Approximately 7 fully matching, plus 22 partially matching documents found.

Latest Intelligence

Deal Watch October 2016

$330m. Neurology 2016. Aspen. 5 anesthetics. $770m royalties. $592m. 1.3. Neurology 2014.
Deal Watch September 2016

Reflecting a long standing business relationship, Aspen paid GSK £180m to acquire Ultiva, Nimbex, Tracrium, Mivacron and Anectinein, plus up to £100m in milestone payments. ... 500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva,
Deal Watch June 2016

Meanwhile AstraZeneca has out-licensed ex-US rights to a portfolio of seven anaesthetics to Aspen. ... Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and
Pharma deals in May 2015

360. Aspen/ Strides Arcolab. Divestment. Range of branded and generic drugs.
Deal Watch table for January 2015

Licence, option and collaboration. 164. Novartis/Aspen. Purchase of the heparin based anticoagulant Mono-Embolex, with sales of 68m in 2013.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

Competition from within

Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘ BRIC’ markets (Brazil,
Compliance Hub Ltd

Address:. Aspen Farm. Sheep Lane Woburn. Bedfordshire. MK17 9HD. UK.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Senior Account Manager / Account Director: Great salary and bebefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Senior Account Manager – Med Comms – Kent: Salary TBC

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Account Manager or AD - Medical Communications: Salary TBC

Senior Medical Writer: Great salary and benefits

Senior Medical Writer: Great salary and bebefits

Senior Programme Executive: Salary TBC

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Medical Writer - (London, Brighton or Copenhagen): Competitive

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Scientific Director: Great salary and bebefits

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Account Manager – Med Comms – London: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Subscribe to our email news alerts

PMHub

Add my company

infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

No Voice, No Choice: Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Pharma’s isolated islands of innovation: With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit: What does it mean for the life science sector?...